Viewing Study NCT05636293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-05-14 @ 6:18 PM
Study NCT ID: NCT05636293
Status: RECRUITING
Last Update Posted: 2025-11-17
First Post: 2022-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Double Blind, Placebo-controlled Trial to Establish Safety and Efficacy of Ritlecitinib in Celiac Disease Patients in Remission
Sponsor: Massachusetts General Hospital
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Celiac Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Celiac Disease View
None Gluten View
None Gluten Challenge View
None Ritlecitinib View